To manage ABA research recruitment selection payment dual roles and undue influence, define the eligible population, scientific reason, recruitment source, privacy route, recruiter relationship, compensation, costs, alternatives, and effect of refusal or withdrawal. Route materials through the required review. Separate treatment, supervision, employment, grades, payer access, and ordinary benefits from participation, and provide an independent question path when power or dependency may affect voluntary choice.

Define Elena's governed activity and unit

Recruitment quality depends on whom the project invites, who asks, what the person may fear losing, and whether the reviewed message matches the real choice. Teams asking how to manage ABA research recruitment selection payment dual roles and undue influence need the exact activity, people, purpose, design, data, site, sponsor, funding, institutional scope, authority, current version, participant protections, and unresolved facts before work begins.

Build Elena's participant recruitment and influence review

Elena records inclusion and exclusion, rationale, outreach source, records screening, privacy permission, recruiter and relationship, treating role, supervisory or employment authority, school role, timing, location, language, disability access, recruitment script, claims, compensation amount and schedule, expenses, referral incentives, ordinary-care boundary, alternative services, refusal and withdrawal language, independent contact, complaint route, reviewer, approved version, outreach dates, response, and enrollment state. Participation status stays out of routine performance and care decisions unless a governing source requires otherwise.

Protect participants and ordinary care in Elena's workflow

Elena's fifteen recruitment packages for clients, caregivers, staff, students, and community participants must preserve client dignity, ordinary clinical access, voluntary choice, privacy, communication and AAC, authorized decision-making, safety response, equitable treatment, complaints, and freedom from retaliation. A research label, consent signature, payment, supervisor approval, or publication goal cannot expand a role or erase a required protection.

Work through Elena's fictional example

Elena reviews 15 packages. Ten pass initial selection, privacy, influence, payment, access, and message review. Two need an independent recruiter, one removes a care-priority implication, one revises a completion-based payment schedule, and one adds an accessible nonportal response route. Preserve every proposed, classified, reviewed, approved, exempted, enrolled, changed, reported, published, corrected, held, withdrawn, and closed state with its original version, owner, date, conditions, and validation.

Use Elena's denominator carefully

Initial package readiness is 10 of 15, or 66.7%. The five revised packages remain in the cohort. Contacted, reached, screened, eligible, consented, enrolled, completed, withdrew, and retained are distinct states.

Assign Elena's decisions to authorized owners

Elena prepares materials. The authorized reviewing body approves recruitment and payment where required. Treating clinicians, supervisors, educators, and employers stay within their roles. Privacy and access owners review channels. The prospective participant decides without promises or penalties outside the approved arrangement.

Address Elena's main interpretation risk

A modest payment can still exert pressure when access to care, employment, grades, immigration, supervision, or a valued relationship appears connected. Analyze the whole context rather than the dollar amount alone.

Verify Elena's research control in practice

Elena role-plays recruitment with someone who depends on the recruiter and asks what happens after refusal, withdrawal, missed visits, or incomplete tasks. Any perceived loss beyond the approved terms triggers a revised route.

Place Elena's project inside organizational accountability

Elena's participant recruitment and influence review uses the CASP Organizational Guidelines public overview only for high-level business, clinical-operations, and risk-management scope in autism service organizations. CASP sells the detailed guidelines. The workflow here is Finni's editorial governance model, not a CASP research protocol, regulatory determination, or institutional approval.

Apply the BACB research duties to Elena's covered roles

Elena's role review uses the current BACB Ethics Code, which applies to BCBA and BCaBA certificants and people who completed an application. Its research section addresses applicable review, participant welfare, informed consent, confidentiality, competence, conflicts, integrity, authorship, publication, and corrections. BACB has no separate organization or corporation jurisdiction, so institutional and legal controls remain necessary.

Anchor Elena's federal scope to the current HHS rule

Elena's federal analysis starts with the HHS 45 CFR 46 page, reviewed in February 2025, which identifies the 2018 Requirements and added subparts for specified populations. Applicability depends on funding, conduct, assurance, institution, activity, and other facts. The page is an authoritative starting point, while the current rule and responsible institution control the determination.

Use the OHRP decision charts as aids for Elena

Elena's reviewer may use the OHRP 2018 Requirements decision charts to organize research, human-subject, exemption, continuing-review, and consent-waiver questions. OHRP calls the charts generalizations and directs users to the full applicable text. They support intake and discussion; they do not authorize an investigator to self-approve a project.

Classify quality improvement carefully for Elena

Elena's project label follows the OHRP Quality Improvement Activities FAQs. OHRP explains that intent to publish is insufficient to decide whether QI is research and that some QI can be nonexempt human-subjects research. Purpose, design, activity, coverage, and an authorized determination matter more than the label chosen by the project team.

Separate HIPAA research permission for Elena

Elena's privacy review uses HHS research guidance under HIPAA, which explains that covered entities may use or disclose PHI for research with individual authorization or through limited rule-defined paths without authorization. Common Rule consent, IRB action, HIPAA authorization or waiver, data-owner approval, and contract terms remain separate decisions even when one document combines information.

Treat informed consent as a process for Elena

Elena's communication plan draws on the OHRP Informed Consent FAQs. OHRP flags that the FAQ predates the 2018 Requirements and 2024 conforming changes, while retaining general nonbinding guidance. Use the current regulation and review decision. The FAQ describes prospective, legally effective, voluntary information exchange with questions and a real choice to join, continue, or withdraw.

Apply child-research requirements precisely for Elena

Elena's child-participant route uses current 45 CFR 46 Subpart D, amended in October 2024. The IRB determines adequate provisions for parental or guardian permission and for child assent when the child is capable, subject to the rule's conditions and possible waivers. Clinical assent policies and research assent determinations should be recorded separately.

Distinguish adverse events and unanticipated problems for Elena

Elena's incident logic uses OHRP guidance on unanticipated problems and adverse events. The guidance explains that only a subset of adverse events are unanticipated problems and describes unexpectedness, relation or possible relation, and increased risk as the three-part analysis. Use the current protocol, institution, and rules for actual reporting decisions and deadlines.

Scope research-misconduct handling for Elena

Elena's integrity route recognizes the 2024 final rule revising 42 CFR Part 93. The rule became effective January 1, 2025, and its regulatory requirements apply beginning January 1, 2026, to covered Public Health Service research-misconduct matters. Allegations received before that applicability date generally follow the 2005 rule unless the institution and respondent elect the new rule in writing. The current rule addresses fabrication, falsification, and plagiarism and excludes honest error or differences of opinion. Other sponsors, institutions, journals, employers, and laws can use different processes; preserve allegations as allegations until the authorized process decides them.

Make Elena's participation process accessible

Elena's access plan uses DOJ effective-communication guidance for covered title II or title III entities. The appropriate aid or service depends on the interaction's nature, length, complexity, context, and the person's usual communication method. Apply the actual entity and rule, preserve AAC and authorship, and test consent, recruitment, questions, incident notices, and withdrawal routes in the formats participants use.

Choose Elena's next review trigger

Review after a new recruiter, population, payment, channel, waitlist, treating relationship, site, language, recruitment volume, complaint, or enrollment disparity. Record the changed fact, affected people and records, immediate protection, governing source, decision owner, reporting or amendment route, deadlines, communication, and validation result.

Close Elena's record with accountable evidence

Review the participant recruitment and influence review with Elena, investigators, qualified clinicians, the institution or reviewing body, participant representatives as applicable, and the specialists named in the manifest. Confirm that service, QI, evaluation, research, review, consent, privacy, safety, data, employment, authorship, publication, and misconduct routes remain distinct; all conditions are traceable; access is tested; and unresolved work has an accountable endpoint. Keep this page draft and noindex until every required review is complete.

Related resources

Sources